(*) EU Approval Date: ?
(*) USA Approval Date: 2008. 04.10.
>Regadenoson Inj.
Company
Company Licensee EU
Mechanism of Action>
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 11
Patent>UpDate: 2011. 04.05.
TradeMark EU (DE & UK)
TradeMark USA
TradeMark USA Web-Site